glutathione and triple negative breast cancer Metabolic interplay between exogenous cystine glutamine dependence in triple-negative NRF2 activation by cysteine as
NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery Mitochondrial Redox Vulnerabilities in Triple Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect
Pay in 4 interest-free payments of $5.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11




